1.
Bray F,
Ferlay J,
Soerjomataram I,
Siegel RL,
Torre LA,
Jemal A.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin.
2018;68(6):394-424.
doi:10.3322/caac.21492
2.
Tryfonidis K,
Senkus E,
Cardoso MJ,
Cardoso F.
Management of locally advanced breast cancer—perspectives and future directions.
Nat Rev Clin Oncol.
2015;12(3):147-162.
doi:10.1038/nrclinonc.2015.13
3.
Choi HY,
Park M,
Seo M,
Song E,
Shin SY,
Sohn Y-M.
Preoperative Axillary Lymph Node Evaluation in Breast Cancer.
Ultrasound Q.
2017;33(1):6-14.
doi:10.1097/RUQ.0000000000000277
4.
Peppe A,
Wilson R,
Pope R,
Downey K,
Rusby J.
The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).
The Breast.
2017;35:104-108.
doi:10.1016/j.breast.2017.05.015
5.
Bedi DG,
Krishnamurthy R,
Krishnamurthy S,
et al.
Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study.
AJR Am J Roentgenol.
2008;191(3):646-652.
doi:10.2214/AJR.07.2460
6.
Lyman GH,
Somerfield MR,
Bosserman LD,
Perkins CL,
Weaver DL,
Giuliano AE.
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
J Clin Oncol.
2017;35(5):561-564.
doi:10.1200/JCO.2016.71.0947
7.
Pegolo E,
Puppin C,
Gerometta A,
Damante G,
Puglisi F,
Di Loreto C.
One-step nucleic acid amplification (OSNA) for intraoperative evaluation of sentinel lymph node status in breast cancer: a comparative study between CK19 protein expression and CK19 mRNA level in primary tumors and lymph node metastasis.
Virchows Arch.
2013;463(1):7-15.
doi:10.1007/s00428-013-1440-2
8.
Specht J,
Gralow JR.
Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer.
Semin Radiat Oncol.
2009;19(4):222-228.
doi:10.1016/j.semradonc.2009.05.001
9.
Liu S V,
Melstrom L,
Yao K,
Russell CA,
Sener SF.
Neoadjuvant therapy for breast cancer.
J Surg Oncol.
2010;101(4):283-291.
doi:10.1002/jso.21446
10.
Kim WH,
Kim HJ,
Park HY,
et al.
Axillary Pathologic Complete Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer Patients: A Predictive Model Integrating the Imaging Characteristics of Ultrasound Restaging with Known Clinicopathologic Characteristics.
Ultrasound Med Biol.
December 2018.
doi:10.1016/j.ultrasmedbio.2018.10.026
11.
Diepstraten SCE,
Sever AR,
Buckens CFM,
et al.
Value of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Preventing Completion Axillary Lymph Node Dissection in Breast Cancer: A Systematic Review and Meta-Analysis.
Ann Surg Oncol.
2014;21(1):51-59.
doi:10.1245/s10434-013-3229-6
12.
Kuroi K,
Toi M,
Tsuda H,
Kurosumi M,
Akiyama F.
Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer.
Breast Cancer.
2006;13(1):38-48.